Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
12 December 2012
HIV/AIDS Intellectual property and trade Research and development Tropical & neglected diseases Tuberculosis Vaccines

Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases

7 min
Banuna is in the MSF hospital in Doro with her mother Arabiya. Banuna just woke up from a five day coma, due to Malaria. The doctors did not think she was going to make it, her waking up is a small miracle. Her mother Arabiya says she was afraid of seeing her like that, she says "it was like she was dead". Photograph by Olga Victoire Photograph by Olga Victoire
Press release
Press release |
06 December 2012
Tropical & neglected diseases

New diagnostics and treatment offer new hope for sleeping sickness but who will use them?

Press release |
05 December 2012
Intellectual property and trade Vaccines
Kenya

MSF Urges GAVI to Extend Vaccine Prices to Humanitarian Actors to Help Close Gap of Unvaccinated Children

Press release |
22 November 2012
HIV/AIDS Intellectual property and trade Malaria Malnutrition Research and development Tropical & neglected diseases Tuberculosis Vaccines

International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients

Primrose and her child Panashe as doctors confirm the seven-year-old boy is suffering from TB. Photograph by Brendan Bannon
Press release
Press release |
15 November 2012
Intellectual property and trade Tuberculosis

Standard TB test failing to detect the disease in children 93% of the time

Medical officer Neisha Mohess, scans a sample of sputum for loading into an automated molecular TB diagnostic machine called GeneXpert. Photograph by Jose Cendon
Press release
Press release |
13 November 2012
Intellectual property and trade Tuberculosis

Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time

Press release |
08 November 2012
Vaccines
AfricaNiger

Research results show need to tailor vaccines to improve their impact

HepC_India_SofHearingProtest_Feb2016 Photograph by MSF
Press release
Press release |
02 October 2012
HIV/AIDS Intellectual property and trade
ZimbabweThailand

MSF launches online resource for challenging unwarranted drug patents

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury